We are live on
!
Find out more
CCMINC
Cardinal Capital Management Inc (North Carolina) Portfolio holdings
AUM
$826M
1-Year Est. Return
32.06%
This Fund
S&P 500
This Quarter
Est. Return
+0.31%
1 Year Est. Return
+32.06%
3 Year Est. Return
+77.59%
5 Year Est. Return
+100.35%
10 Year Est. Return
+1,178.43%
AUM
$594M
AUM Growth
-$20.9M
(-3.4%)
Cap. Flow
-$13.8M
Cap. Flow
% of AUM
-2.32%
Top 10 Holdings %
Top 10 Hldgs %
27.13%
Holding
140
New
1
Increased
114
Reduced
17
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amcor
AMCR
|
+$1M |
| 2 |
Solventum
SOLV
|
+$715K |
| 3 |
KE
Kimball Electronics
KE
|
+$304K |
| 4 |
Intel
INTC
|
+$256K |
| 5 |
Ziff Davis
ZD
|
+$256K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.57M |
| 2 |
Eli Lilly
LLY
|
+$3.95M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$3.08M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$2.71M |
| 5 |
Forward Air
FWRD
|
+$1.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.38% |
| 2 | Technology | 21.66% |
| 3 | Industrials | 13.28% |
| 4 | Consumer Staples | 11.85% |
| 5 | Financials | 11.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
| $786K | 0.13% |
15,340
| – | – |
|
127
Fortrea Holdings
FTRE
$1.74B
| $736K | 0.12% |
31,548
+827
| +3% | +$25.7K |
|
128
Tompkins Financial
TMP
$1.44B
| $629K | 0.11% |
12,863
+1,304
| +11% | +$60.1K |
|
|
129
Solventum
SOLV
$14.5B
| $623K | 0.1% |
+11,781
| New | +$715K |
|
130
Worthington Steel
WS
$1.94B
| $413K | 0.07% |
12,376
+130
| +1% | +$4.25K |
|
131
Haleon
HLN
$43.2B
| $382K | 0.06% |
46,231
+1,140
| +3% | +$9.53K |
|
132
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $317K | 0.05% |
581
+33
| +6% | +$17.3K |
|
|
AVDX
133
DELISTED
AvidXchange
AVDX
| $174K | 0.03% |
14,441
| – | – |
|
134
Embecta
EMBC
$269M
| $147K | 0.02% |
11,753
+1,691
| +17% | +$20.5K |
|
|
135
Biogen
BIIB
$30.9B
| – | – |
-30,467
| Closed | -$6.57M |
|
|
136
Bristol-Myers Squibb
BMY
$130B
| – | – |
-56,860
| Closed | -$3.08M |
|
|
137
Forward Air
FWRD
$658M
| – | – |
-42,164
| Closed | -$1.31M |
|
138
Heartland Express
HTLD
$950M
| – | – |
-58,015
| Closed | -$694K |
|
139
Monro
MNRO
$359M
| – | – |
-32,142
| Closed | -$1.01M |
|
140
NRC Health Common Stock
NRC
$456M
| – | – |
-26,988
| Closed | -$1.07M |
|
Similar funds
FPCP
SCM
ECM
VT
CCM
RAM
AC
ACM
Cardinal Capital Management Inc (North Carolina)'s Q2 2024 Portfolio in Review
As of Q2 2024, Cardinal Capital Management Inc (North Carolina) held 140 positions worth $594M, down 3.4% from $615M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Cardinal Capital Management Inc (North Carolina)'s Q2 2024 filing shows 1 new, 114 increased, 17 reduced and 6 closed positions. Its largest new stake was Solventum: 11,781 shares worth $623K. The largest sale was Biogen, an estimated $6.57M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.
- Cardinal Capital Management Inc (North Carolina)'s largest Q2 2024 buy was Solventum: 11,781 shares worth $623K.
- Cardinal Capital Management Inc (North Carolina) added most to Amcor in Q2 2024, an estimated $1M increase.
- Cardinal Capital Management Inc (North Carolina)'s biggest Q2 2024 reduction was Eli Lilly, cutting an estimated $3.95M.
- Cardinal Capital Management Inc (North Carolina) fully exited Biogen in Q2 2024, selling an estimated $6.57M.
- Cardinal Capital Management Inc (North Carolina)'s ten largest holdings make up 27% of its $594M portfolio in Q2 2024.
- Cardinal Capital Management Inc (North Carolina) opened 1 new position and closed 6 in Q2 2024.
- Cardinal Capital Management Inc (North Carolina)'s portfolio value fell 3.4% quarter-over-quarter to $594M.
Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q2 2024, filed 12 Jul 2024.